The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO
- PMID: 19487625
- DOI: 10.1001/archgenpsychiatry.2009.43
The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO
Abstract
Context: Most antipsychotics are thought to have an effect on D(2) and D(3) receptors. The development of carbon 11-labeled (+)-4-propyl-9-hydroxynaphthoxazine ([(11)C]-(+)-PHNO), the first agonist radioligand with higher affinity for D(3) than D(2) receptors, allows one to differentiate the effects of antipsychotics on high-affinity vs low-affinity sites of the D(2) receptor and on D(3) vs D(2) receptor subtypes.
Objectives: To examine the effects of antipsychotics (clozapine, risperidone, or olanzapine) on the high- vs high- + low-affinity sites of the D(2) and D(3) receptors by comparing the [(11)C]-(+)-PHNO and [(11)C]raclopride binding in the D(3) receptor-rich (globus pallidus and ventral striatum) and D(2) receptor-rich (caudate and putamen) regions.
Design: Two sequential studies with different participants and appropriate controls were performed. The first compared the occupancy produced by 3 antipsychotics as measured with [(11)C]-(+)-PHNO and [(11)C]raclopride. The second was a double-blind, placebo-controlled experiment to compare the effect of pramipexole (a D(3) receptor-preferring agonist) vs placebo on the increased [(11)C]-(+)-PHNO signal observed in the globus pallidus of patients.
Setting: Positron Emission Tomography Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Participants: Twenty-three patients with schizophrenia and 23 healthy controls.
Main outcome measures: Antipsychotic occupancies as measured with [(11)C]-(+)-PHNO and [(11)C]raclopride.
Results: The antipsychotic-treated patients showed high occupancies with both [(11)C]-(+)-PHNO and [(11)C]raclopride in the dorsal striatum, with [(11)C]raclopride occupancies about 20% higher. Most strikingly, patients did not show any occupancy with [(11)C]-(+)-PHNO in the globus pallidus as compared with normal controls or with their own scans using [(11)C]raclopride. This unblocked [(11)C]-(+)-PHNO signal was displaced by a single dose of pramipexole.
Conclusions: Antipsychotics block both the high- and low-affinity states of the D(2) receptors across the brain, but antipsychotic treatment does not block the [(11)C]-(+)-PHNO signal in the D(3) receptor-rich regions, despite the ongoing D(2) receptor blockade. This [(11)C]-(+)-PHNO signal in regions such as the globus pallidus seems increased despite antipsychotic treatment and is displaceable by a D(3) receptor-preferring agonist. The radiotracer [(11)C]-(+)-PHNO and the data open up new avenues for exploring the potential therapeutic significance of the D(3) receptor in schizophrenia.
Similar articles
-
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.Hum Brain Mapp. 2008 Apr;29(4):400-10. doi: 10.1002/hbm.20392. Hum Brain Mapp. 2008. PMID: 17497628 Free PMC article.
-
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.Synapse. 2006 Dec 1;60(7):485-95. doi: 10.1002/syn.20325. Synapse. 2006. PMID: 16952157
-
Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO.Schizophr Res. 2011 Sep;131(1-3):63-8. doi: 10.1016/j.schres.2011.05.005. Schizophr Res. 2011. PMID: 21684721
-
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.Mol Psychiatry. 1998 Mar;3(2):123-34. doi: 10.1038/sj.mp.4000336. Mol Psychiatry. 1998. PMID: 9577836 Review.
-
[Cognition, schizophrenia and the effect of antipsychotics].Encephale. 2006 May-Jun;32(3 Pt 1):341-50. doi: 10.1016/s0013-7006(06)76162-0. Encephale. 2006. PMID: 16840928 Review. French.
Cited by
-
Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia.Naunyn Schmiedebergs Arch Pharmacol. 2013 Feb;386(2):107-24. doi: 10.1007/s00210-012-0797-0. Epub 2012 Sep 22. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23001156 Free PMC article.
-
In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO.Neuropsychopharmacology. 2011 Mar;36(4):887-95. doi: 10.1038/npp.2010.228. Epub 2010 Dec 22. Neuropsychopharmacology. 2011. PMID: 21178982 Free PMC article.
-
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.BMC Psychiatry. 2017 Aug 24;17(1):305. doi: 10.1186/s12888-017-1459-z. BMC Psychiatry. 2017. PMID: 28836957 Free PMC article.
-
In vivo imaging of cerebral dopamine D3 receptors in alcoholism.Neuropsychopharmacology. 2014 Jun;39(7):1703-12. doi: 10.1038/npp.2014.18. Epub 2014 Jan 28. Neuropsychopharmacology. 2014. PMID: 24469594 Free PMC article.
-
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo.Front Psychiatry. 2022 Mar 24;13:785592. doi: 10.3389/fpsyt.2022.785592. eCollection 2022. Front Psychiatry. 2022. PMID: 35401257 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical